| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4a8f4574431313d4a3c5cb0df8d1b56a |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D519-00 |
| filingDate |
2022-03-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_863292f876b77c3e0dd7da80d05c3c39
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_819c530aab62a2de2f156b444e7e1b39
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d2842e626b91b346fa74f94e9a069cb3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_204b36d6ad9a7e9d2f918b271e92dbf2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_77a6caca7d081841281d296940a36f3c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2b1bb671a68842e60201a228c30df454 |
| publicationDate |
2022-09-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2022188802-A1 |
| titleOfInvention |
Use of wee1 kinase inhibitors in the treatment of cancer |
| abstract |
Provided is a use of Wee1 kinase inhibitors in the treatment of cancer. In particular, provided is a use of Wee1 kinase inhibitors in the preparation of drugs for the treatment of cancers with Histone H3K27M mutation. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023170065-A1 |
| priorityDate |
2021-03-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |